Julia Dambacher

2.6k total citations
24 papers, 2.0k citations indexed

About

Julia Dambacher is a scholar working on Immunology, Oncology and Genetics. According to data from OpenAlex, Julia Dambacher has authored 24 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 12 papers in Oncology and 9 papers in Genetics. Recurrent topics in Julia Dambacher's work include Cytokine Signaling Pathways and Interactions (10 papers), Inflammatory Bowel Disease (7 papers) and Chemokine receptors and signaling (4 papers). Julia Dambacher is often cited by papers focused on Cytokine Signaling Pathways and Interactions (10 papers), Inflammatory Bowel Disease (7 papers) and Chemokine receptors and signaling (4 papers). Julia Dambacher collaborates with scholars based in Germany and United States. Julia Dambacher's co-authors include Stephan Brand, Burkhard Göke, Florian Beigel, Christoph J. Auernhammer, Helmut M. Diepolder, Torsten Olszak, Jan‐Michel Otte, Gergana Dobreva, Rudolf Grosschedl and Sören T. Eichhorst and has published in prestigious journals such as Genes & Development, Gastroenterology and Gut.

In The Last Decade

Julia Dambacher

24 papers receiving 2.0k citations

Peers

Julia Dambacher
Sanae Fujino Japan
John B. Mumm United States
Iwao Sekigawa Japan
Manjiri Sathe United States
Francesco Tonelli Italy
Shirley Zhu United States
John Prehn United States
Maya Gavrieli United States
Geoffrey L. Stephens United States
Amala Alag United States
Sanae Fujino Japan
Julia Dambacher
Citations per year, relative to Julia Dambacher Julia Dambacher (= 1×) peers Sanae Fujino

Countries citing papers authored by Julia Dambacher

Since Specialization
Citations

This map shows the geographic impact of Julia Dambacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Dambacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Dambacher more than expected).

Fields of papers citing papers by Julia Dambacher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Dambacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Dambacher. The network helps show where Julia Dambacher may publish in the future.

Co-authorship network of co-authors of Julia Dambacher

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Dambacher. A scholar is included among the top collaborators of Julia Dambacher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Dambacher. Julia Dambacher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dambacher, Julia, Florian Beigel, Kathrin Zitzmann, et al.. (2008). The role of interleukin-22 in hepatitis C virus infection. Cytokine. 41(3). 209–216. 79 indexed citations
2.
Seiderer, Julia, Julia Dambacher, Cornelia Tillack, et al.. (2008). Genotype–phenotype analysis of the CXCL16 p.Ala181Val polymorphism in inflammatory bowel disease. Clinical Immunology. 127(1). 49–55. 12 indexed citations
3.
Dambacher, Julia, Florian Beigel, Enrico N. De Toni, et al.. (2008). The role of the novel Th17 cytokine IL-26 in intestinal inflammation. Gut. 58(9). 1207–1217. 198 indexed citations
4.
Seiderer, Julia, Stephan Brand, Julia Dambacher, et al.. (2007). Adalimumab in patients with Crohn’s disease – safety and efficacy in an open‐label single centre study. Alimentary Pharmacology & Therapeutics. 25(7). 787–796. 31 indexed citations
5.
Dambacher, Julia, Florian Beigel, Julia Seiderer, et al.. (2007). Interleukin 31 mediates MAP kinase and STAT1/3 activation in intestinal epithelial cells and its expression is upregulated in inflammatory bowel disease. Gut. 56(9). 1257–1265. 88 indexed citations
6.
Brand, Stephan, Julia Dambacher, Florian Beigel, et al.. (2007). IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro. American Journal of Physiology-Gastrointestinal and Liver Physiology. 292(4). G1019–G1028. 96 indexed citations
7.
Seiderer, Julia, Julia Dambacher, Simone Pfennig, et al.. (2007). The role of the selenoprotein S (SELS) gene −105G>A promoter polymorphism in inflammatory bowel disease and regulation of SELS gene expression in intestinal inflammation. Tissue Antigens. 70(3). 238–246. 33 indexed citations
8.
9.
Brand, Stephan, Florian Beigel, Torsten Olszak, et al.. (2006). IL-22 is increased in active Crohn’s disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. American Journal of Physiology-Gastrointestinal and Liver Physiology. 290(4). G827–G838. 454 indexed citations
10.
Seiderer, Julia, Fabian Schnitzler, Stephan Brand, et al.. (2006). Homozygosity for theCARD15frameshift mutation 1007fs is predictive of early onset of Crohn's disease with ileal stenosis, entero-enteral fistulas, and frequent need for surgical intervention with high risk of re-stenosis. Scandinavian Journal of Gastroenterology. 41(12). 1421–1432. 55 indexed citations
11.
Dambacher, Julia, Julia Seiderer, Astrid Konrad, et al.. (2006). The +1059G/C polymorphism in the C‐reactive protein (CRP) gene is associated with involvement of the terminal ileum and decreased serum CRP levels in patients with Crohn's disease. Alimentary Pharmacology & Therapeutics. 24(7). 1105–1115. 33 indexed citations
12.
Dambacher, Julia, Julia Seiderer, Fabian Schnitzler, et al.. (2006). Macrophage migration inhibitory factor (MIF) −173G/C promoter polymorphism influences upper gastrointestinal tract involvement and disease activity in patients with Crohnʼs disease. Inflammatory Bowel Diseases. 13(1). 71–82. 42 indexed citations
13.
Dambacher, Julia, Torsten Olszak, Martin Storr, et al.. (2006). IL-22 mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression. Zeitschrift für Gastroenterologie. 44(10). 1 indexed citations
14.
Beigel, Florian, Julia Dambacher, Martin Storr, et al.. (2006). The novel Lambda-interferons IL-28A and IL-29 inhibit HCV replication in vitro and hepatic IL-28 mRNA expression is increased in HCV and CMV infection in vivo. Zeitschrift für Gastroenterologie. 44(10). 1 indexed citations
15.
Brand, Stephan, Kathrin Zitzmann, Julia Dambacher, et al.. (2005). SOCS-1 inhibits expression of the antiviral proteins 2′,5′-OAS and MxA induced by the novel interferon-λs IL-28A and IL-29. Biochemical and Biophysical Research Communications. 331(2). 543–548. 74 indexed citations
16.
Brand, Stephan, Florian Beigel, Torsten Olszak, et al.. (2005). IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression. American Journal of Physiology-Gastrointestinal and Liver Physiology. 289(5). G960–G968. 186 indexed citations
17.
Brand, Stephan, Torsten Olszak, Florian Beigel, et al.. (2005). Cell differentiation dependent expressed CCR6 mediates ERK‐1/2, SAPK/JNK, and Akt signaling resulting in proliferation and migration of colorectal cancer cells. Journal of Cellular Biochemistry. 97(4). 709–723. 125 indexed citations
18.
Brand, Stephan, Julia Dambacher, Fabian Schnitzler, et al.. (2005). Increased Expression of the Chemokine Fractalkine in Crohn's Disease and Association of the Fractalkine Receptor T280M Polymorphism with a Fibrostenosing Disease Phenotype. The American Journal of Gastroenterology. 101(1). 99–106. 84 indexed citations
19.
Brand, Stephan, Julia Dambacher, Florian Beigel, et al.. (2005). CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation. Experimental Cell Research. 310(1). 117–130. 148 indexed citations
20.
Dobreva, Gergana, Julia Dambacher, & Rudolf Grosschedl. (2003). SUMO modification of a novel MAR-binding protein, SATB2, modulates immunoglobulin μ gene expression. Genes & Development. 17(24). 3048–3061. 223 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sanae Fujino Breakdown of academic impact, for papers by John B. Mumm Breakdown of academic impact, for papers by Iwao Sekigawa Breakdown of academic impact, for papers by Manjiri Sathe Breakdown of academic impact, for papers by Francesco Tonelli Breakdown of academic impact, for papers by Shirley Zhu Breakdown of academic impact, for papers by John Prehn Breakdown of academic impact, for papers by Maya Gavrieli Breakdown of academic impact, for papers by Geoffrey L. Stephens Breakdown of academic impact, for papers by Amala Alag
Rankless by CCL
2026